Market Tracker

02/27 6:02pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

15.07
Delayed Data
As of Feb 27
 -0.21 / -1.37%
Today’s Change
6.88
Today|||52-Week Range
15.94
+56.17%
Year-to-Date
A Steady but Sloppy Day
Feb 24 / TheStreet.com
This Looks Like Routine Selling
Feb 23 / TheStreet.com
A Steady but Sloppy Day
Feb 24 / TheStreet.com
This Looks Like Routine Selling
Feb 23 / TheStreet.com

Today’s Trading

Previous close15.28
Today’s open15.24
Day’s range14.86 - 15.34
Volume724,341
Average volume (3 months)1,886,946
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+19.60%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp-1.06-1.94%
NVAXNovavax Inc-0.16-1.72%
RLYPRelypsa Inc-0.17-0.44%
RDUSRadius Health Inc-2.67-5.89%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMarch 3, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts